Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
Maryam Nakhjavani, Sarah Shigdar
Topics & Concepts
AptamerMonoclonal antibodyImmunotherapyTriple-negative breast cancerPD-L1Breast cancerCancer immunotherapyCancer researchTargeted therapyMedicineCancerComputational biologyAntibodyImmunologyBiologyInternal medicineMolecular biologyMonoclonal and Polyclonal Antibodies ResearchAdvanced biosensing and bioanalysis techniquesImmunotherapy and Immune Responses